Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent glioma.

S V Rajkumar; P A Burch; S Nair; R P Dinapoli; B Scheithauer; J R O'Fallon; P S Etzell; J M Leitch; R F Morton; R S Marks

doi:10.1097/00000421-199904000-00012

Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent glioma.

Identifier:nobleid.org/w1/20260515/CBFE5159

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CBFE5159.svg?ark=w1%2F20260515%2FCBFE5159)](https://nobleid.org/work/w1/20260515/CBFE5159)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent glioma.

Identifier:nobleid.org/w1/20260515/CBFE5159

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CBFE5159.svg?ark=w1%2F20260515%2FCBFE5159)](https://nobleid.org/work/w1/20260515/CBFE5159)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work